Read Time:6 Second
Medicare has reached a preliminary decision to cover Biogen’s Alzheimer’s drug, Aduhelm, for patients who are in approved clinical trials.
Medicare has reached a preliminary decision to cover Biogen’s Alzheimer’s drug, Aduhelm, for patients who are in approved clinical trials.
Average Rating
More Stories
AEW Collision (5/31/2025)
MLB Games (5/31/2025)
NBA Playoffs: Eastern Conference Finals: Game 6 (5/31/2025) (Finals Are Set)